Götz Nowak

840 total citations
35 papers, 667 citations indexed

About

Götz Nowak is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Götz Nowak has authored 35 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 11 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Götz Nowak's work include Blood Coagulation and Thrombosis Mechanisms (16 papers), Heparin-Induced Thrombocytopenia and Thrombosis (10 papers) and Platelet Disorders and Treatments (6 papers). Götz Nowak is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (16 papers), Heparin-Induced Thrombocytopenia and Thrombosis (10 papers) and Platelet Disorders and Treatments (6 papers). Götz Nowak collaborates with scholars based in Germany, Netherlands and United States. Götz Nowak's co-authors include Roland Kaufmann, Karsten Schrör, Elke Bucha, Günter A. Schaub, Katrin Mende, H.C. Hemker, Ramona J. Petrovan, José W.P. Govers‐Riemslag, Erika Glusa and Jan Rosing and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and Kidney International.

In The Last Decade

Götz Nowak

33 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Götz Nowak Germany 16 246 179 155 152 139 35 667
Steven L. Maki United States 12 473 1.9× 116 0.6× 123 0.8× 104 0.7× 71 0.5× 14 735
Kirsty Moore United Kingdom 9 359 1.5× 125 0.7× 19 0.1× 273 1.8× 101 0.7× 25 1.2k
Janice M. Staber United States 16 330 1.3× 41 0.2× 21 0.1× 356 2.3× 69 0.5× 35 946
Mieke Delvaeye Belgium 6 279 1.1× 37 0.2× 52 0.3× 143 0.9× 49 0.4× 9 750
Susanne Witt Germany 10 145 0.6× 60 0.3× 31 0.2× 91 0.6× 28 0.2× 17 362
Uwe Schubert Germany 11 68 0.3× 56 0.3× 58 0.4× 180 1.2× 28 0.2× 16 553
Sadayoshi Sekiguchi Japan 15 270 1.1× 61 0.3× 7 0.0× 150 1.0× 42 0.3× 75 745
Shilun Zheng Canada 16 283 1.2× 90 0.5× 8 0.1× 51 0.3× 32 0.2× 24 562
Hannah J. MacLeod United States 9 165 0.7× 29 0.2× 15 0.1× 87 0.6× 92 0.7× 11 630
Norma B de Bosch Venezuela 14 353 1.4× 14 0.1× 32 0.2× 111 0.7× 97 0.7× 28 766

Countries citing papers authored by Götz Nowak

Since Specialization
Citations

This map shows the geographic impact of Götz Nowak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Götz Nowak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Götz Nowak more than expected).

Fields of papers citing papers by Götz Nowak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Götz Nowak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Götz Nowak. The network helps show where Götz Nowak may publish in the future.

Co-authorship network of co-authors of Götz Nowak

This figure shows the co-authorship network connecting the top 25 collaborators of Götz Nowak. A scholar is included among the top collaborators of Götz Nowak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Götz Nowak. Götz Nowak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pasternack, Ralf, Christiane Pelzer, Michael Sommer, et al.. (2019). Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a). Journal of Thrombosis and Haemostasis. 18(1). 191–200. 28 indexed citations
2.
Blome, Sandra, et al.. (2012). Disseminated intravascular coagulation does not play a major role in the pathogenesis of classical swine fever. Veterinary Microbiology. 162(2-4). 360–368. 10 indexed citations
3.
Böl, Markus, et al.. (2012). A three-dimensional chemo-mechanical continuum model for smooth muscle contraction. Journal of the mechanical behavior of biomedical materials. 13. 215–229. 23 indexed citations
4.
Steinmetzer, Torsten, Bernhard Baum, J. Biela, et al.. (2012). Beyond Heparinization: Design of Highly Potent Thrombin Inhibitors Suitable for Surface Coupling. ChemMedChem. 7(11). 1965–1973. 9 indexed citations
5.
Walter, Thomas, Sebastian Szabo, Tim Süselbeck, et al.. (2011). Investigation of platelet adhesiveness in patients with coronary artery disease and acute myocardial infarction using the platelet adhesion assay (PADA).. PubMed. 57(5-6). 315–20. 1 indexed citations
6.
Nowak, Götz, et al.. (2005). Platelet Adhesion Assay-A New Quantitative Whole Blood Test to Measure Platelet Function. Seminars in Thrombosis and Hemostasis. 31(4). 470–475. 4 indexed citations
7.
Halbmayer, Walter‐Michael, Götz Nowak, & E. Wenzel. (2005). Reliability of Platelet Function Tests and Drug Monitoring. Seminars in Thrombosis and Hemostasis. 31(4). 367–369.
8.
Bucha, Elke, et al.. (2005). Is Platelet Adhesion Assay Able To Quantify Drug-Induced Platelet Dysfunction?. Seminars in Thrombosis and Hemostasis. 31(4). 476–481. 2 indexed citations
9.
Stein, Günter, et al.. (2004). Characterization of the postglomerular renal metabolism of lepirudin in healthy volunteers. Thrombosis Research. 113(3-4). 187–195. 2 indexed citations
10.
Nowak, Götz. (2003). The Ecarin Clotting Time, a Universal Method to Quantify Direct Thrombin Inhibitors. Pathophysiology of Haemostasis and Thrombosis. 33(4). 173–183. 118 indexed citations
11.
Nowak, Götz. (2002). Pharmacology of Recombinant Hirudin. Seminars in Thrombosis and Hemostasis. 28(5). 415–424. 22 indexed citations
12.
Zieger, Michael, et al.. (2001). A Novel PAR-1-Type Thrombin Receptor Signaling Pathway: Cyclic AMP-Independent Activation of PKA in SNB-19 Glioblastoma Cells. Biochemical and Biophysical Research Communications. 282(4). 952–957. 19 indexed citations
13.
Nowak, Götz. (2001). Clinical Monitoring of Hirudin and Direct Thrombin Inhibitors. Seminars in Thrombosis and Hemostasis. 27(5). 537–542. 43 indexed citations
14.
Bucha, Elke, et al.. (2000). Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure. Kidney International. 58(6). 2478–2484. 17 indexed citations
15.
Kaufmann, Roland, Stephan Patt, Robert Kraft, et al.. (1999). PAR 1-type Thrombin Receptors are Involved in Thrombin-induced Calcium Signaling in Human Meningioma Cells. Journal of Neuro-Oncology. 42(2). 131–136. 14 indexed citations
16.
Mende, Katrin, et al.. (1999). Dipetalogastin, a potent thrombin inhibitor from the blood‐sucking insectDipetalogaster maximus. European Journal of Biochemistry. 266(2). 583–590. 69 indexed citations
17.
Kaufmann, Roland, Stephan Patt, Michael Zieger, Robert Kraft, & Götz Nowak. (1999). Presence of the proteinase-activated receptor-2 (PAR-2) in human brain tumor cells – trypsin- and SLIGRL-induced calcium response in primary cultured meningiomas. Cancer Letters. 139(1). 109–113. 8 indexed citations
18.
Kaufmann, Roland, et al.. (1998). Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells. Neuroreport. 9(4). 709–712. 21 indexed citations
19.
Petrovan, Ramona J., José W.P. Govers‐Riemslag, Götz Nowak, et al.. (1997). Purification and Characterization of Multisquamase, the Prothrombin Activator Present in Echis Multisquamatus Venom. Thrombosis Research. 88(3). 309–316. 17 indexed citations
20.
Nowak, Götz & Elke Bucha. (1995). Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudin. Thrombosis Research. 80(4). 317–325. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026